Latest news
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Shareholders to Connect - ACCESS NewswireACCESS Newswire · Mon, 10 Aug 2026 03:47:13 GMTALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 06:56:07 GMTAldeyra Therapeutics Inc (ALDX) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 16:36:05 GMTAldeyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:37:49 GMTAldeyra Therapeutics, Inc. Q2 2026: Net loss $5.45M, EPS $(0.09) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 11:08:04 GMTAldeyra Therapeutics, Inc. Signs Lease for New Corporate Headquarters in Concord, Massachusetts - marketscreener.commarketscreener.com · Thu, 30 Jul 2026 21:07:00 GMTAldeyra Therapeutics (NASDAQ: ALDX) leases new Concord headquarters space - Stock TitanStock Titan · Thu, 30 Jul 2026 07:00:00 GMT